[PDF][PDF] Transcriptomic Insight and Structural Integration: Repositioning FDA-Approved Methotrexate Derivative for Precision Therapy in Lung Cancer through Drug …
H Tare, V Vaidya, S Fulmali, S Jadhao, M Wankhade… - cancer - irjms.com
In the pursuit of advancing precision therapy for lung cancer, this study explores the
repositioning potential of a FDA-approved methotrexate derivative, with a specific focus on …
repositioning potential of a FDA-approved methotrexate derivative, with a specific focus on …
[PDF][PDF] LC-MS/MS Method Development and Validation for Human Plasma Canagliflozin Determination
Hyperglycemia is treated with canagliflozin (CANA), for determination of CANA in human
plasma, simple, accurate, precise, and reproducible RP-HPLC with mass spectrometry …
plasma, simple, accurate, precise, and reproducible RP-HPLC with mass spectrometry …
[PDF][PDF] Design and Discovery of Silmitasertib-based Drugs as a Potential Casein Kinase II Inhibitor for Cholangiocarcinoma through Hybrid In-silico Ligand-Based …
This research investigates the design and discovery of silmitasertib-based drugs as potential
inhibitors of casein kinase II (CK2) for cholangiocarcinoma using hybrid in-silico methods …
inhibitors of casein kinase II (CK2) for cholangiocarcinoma using hybrid in-silico methods …